Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, February 01, 2015
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Hiden Gas Analyzers at Pittcon 2015
Thursday, January 29, 2015
Company will feature their latest QGA systems for direct real time analysis at Pittcon 2015.

New Additions to IONICON Trace Gas Analyzer Series to be Showcased at Pittcon 2015
Saturday, January 24, 2015
A fast GC add-on for PTR-TOFMS trace gas analyzers and the new PTR-QiTOF are now available.

Automated Catalyst Characterization
Friday, January 23, 2015
Catlab PCS combined microreactor and mass spectrometer system from Hiden.

Bruker HMDB Metabolite Library Launched
Friday, January 16, 2015
Bruker HMDB Metabolite Library to accelerate the accurate mass identification of target compounds in clinical metabolomics launched.

ChromaTOF-HRT® 1.81 Now Available
Monday, January 05, 2015
LECO Corporation is pleased to announce the availability of a major upgrade to its ChromaTOF-HRT brand software platform.

Studying Dissolved Gases in Aqueous Solution
Tuesday, December 09, 2014
HPR-40 mass spectrometer series from Hiden for monitoring dissolved gaseous content.

Fast GC Add-on for IONICON PTR-TOF Instruments
Friday, December 05, 2014
Gas Chromatographic separation now combined with real-time trace gas analysis.

Sysquant® Awarded Two Contracts
Monday, December 01, 2014
Proteome Sciences provide an update on SysQuant ®, its phosphorylation assay that provides insight into normal cell function, disease state and response to drug treatments in patients.

Specialist Analytical Services for the Construction Industry
Tuesday, November 25, 2014
Warwick Analytical Service (WAS) reports on specialist analytical services it has been providing to Normet (UK) Ltd.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 1122
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn